Back to Homepage

Global Polio Vaccine Funding Slashed By 30% In 2026

Aglow News
October 23, 2025
Global Polio Vaccine Funding Slashed By 30% In 2026

Global Polio Vaccine Funding Slashed By 30% In 2026

The shortfall is largely caused by a global drawback in foreign aid, led by the United States, which is also withdrawing from the WHO.The budget of the Global Polio Eradication Initiative, a partnership including the World Health Organization and the Gates Foundation, has been slashed by 30% in 2026.

Funding will also face a $1.7 billion gap up to 2029, the organisation has said.The shortfall is largely caused by a global drawback in foreign aid, led by the United States, which is also withdrawing from the WHO. The partnership will reduce its work in lower-risk areas, unless there are outbreaks, as well as focus on efficiencies.“The significant reductions in funding… mean that certain activities will simply not happen,” said Jamal Ahmed, WHO director of polio eradication, in a press conference on Tuesday, according to Reuters.

Other wealthy donor governments like Germany and the United Kingdom have made cuts, a spokesperson said.In response, the GPEI partners said they plan to focus more on surveillance and vaccination in areas where there is a high risk of polio transmission.The GPEI will also collaborate more with other global health programmes like measles campaigns, and use strategies like fractional dosing – where as little as a fifth of a vaccine dose is used to stretch out supplies and cut costs, as studies have shown this still protects children from infection.Wiping out the paralysis-causing viral disease has been a global health aim for decades.

Article image

Despite significant progress due to mass vaccination since 1988, ending the disease has proved challenging: the first missed deadline for doing so was in 2000.In 2025, there were 36 cases of wild polio in Afghanistan and Pakistan, the two countries where it remains endemic and where essential activities will continue, the GPEI said.

There have been 149 cases of the vaccine-derived form of the virus this year in countries including Nigeria. Cases of both forms have fallen since 2024.

Tags

Related Posts

NCDC Identifies Two Suspected Cases Of Ebola In North-East

NCDC Identifies Two Suspected Cases Of Ebola In North-East

The Nigeria Centre for Disease Control and Prevention (NCDC) has identified two suspected Ebola cases in the North-East, with both individuals isolated as laboratory tests are conducted. The agency stressed that the cases are yet to be confirmed, urging Nigerians to maintain proper hand hygiene, practise good sanitation and follow official public health advisories.

Aglow NewsRead More →
Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan

Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan

AstraZeneca has reported a 23 per cent rise in third-quarter net profit to $3.12 billion, driven largely by strong cancer drug sales, while unveiling a $1.5 billion annual cost-saving programme. The British pharmaceutical giant is also expanding its research pipeline, international investments and development of a potential weight-loss treatment as it targets $80 billion in annual revenue by 2030.

Aglow NewsRead More →
NIGERIA’S INDEX EBOLA PATIENT, HUSBAND EVACUATED TO SWITZERLAND — PATE

NIGERIA’S INDEX EBOLA PATIENT, HUSBAND EVACUATED TO SWITZERLAND — PATE

Coordinating Minister of Health and Social Welfare, Muhammad Ali Pate, has confirmed the evacuation of Nigeria’s first imported Ebola patient and her husband to Switzerland for further care. Although the patient’s condition has improved and she is stable and conscious, Pate warned that she may still be infectious. Meanwhile, the NCDC says 53 contacts have been identified and are being monitored as public health authorities intensify containment measures.

Aglow NewsRead More →

Share this article